BCIQ Profiles

Company Profile Report
1228 data byte Inovio covid vax ph1
BioCentury & Getty Images

Product Development

Inovio COVID vaccine leans toward T cell responses: Data Byte 

Dec 29, 2020 | 2:22 AM GMT

Phase I data for Inovio’s COVID-19 vaccine suggest INO-4800 may stimulate T cell responses more potently than neutralizing responses. The preliminary readout also provided evidence the DNA vaccine induces both CD4+ and CD8+ memory T cell

Read the full 596 word article

How to gain access

Continue reading with a
two-week free trial.